Viewing Study NCT06322667

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-02-24 @ 8:50 AM
Study NCT ID: NCT06322667
Status: RECRUITING
Last Update Posted: 2025-02-18
First Post: 2024-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab
Sponsor: Eisai Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Early Alzheimer's Disease View
None Lecanemab View
None ARIA View